Description
GENOTYPING IGF::OT::IGF
First action · last action
2017-09-28 · 2017-09-28
Transactions
1
First transaction's obligation
$3,999,936
Base + all options value (sum of deltas)
$3,999,936
Extent competed
FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
2
SDVOSB flag on record
No
Parent IDV
VA24013D0054
NAICS
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-09-28+$3,999,936= $3,999,936
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-09-28 | +$3,999,936 | $3,999,936 | GENOTYPING IGF::OT::IGF |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI FW1MQC5H7K56)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026P0555 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · AJ12 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH | $50,000 | FY2026 |
| 36C26126P0469 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $20,000 | FY2026 |
| 36C24E26N0045 | RPO EAST (36C24E) · Q301 · REFERENCE LABORATORY TESTING | $8,000 | FY2026 |
| 36C24E25P0058 | RPO EAST (36C24E) · B504 · SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL | $110,000 | FY2025 |
| 36C24E25N0073 | RPO EAST (36C24E) · Q301 · REFERENCE LABORATORY TESTING | $12,000 | FY2025 |
| 36C24E25D0009 | RPO EAST (36C24E) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2025 |
Other recipients under R405 from RPO EAST (36C24E) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24E26P0004 | FLANAGAN MINDY E | RPO EAST (36C24E) | $66,000 | FY2026 |
| 36C24E26N0035 | CHARLES RIVER LABORATORIES, INC. | RPO EAST (36C24E) | $17,240 | FY2026 |
| 36C24E26N0020 | CHARLES RIVER LABORATORIES, INC. | RPO EAST (36C24E) | $5,747 | FY2026 |
| 36C24E25N0256 | IPSOS PUBLIC AFFAIRS, LLC | RPO EAST (36C24E) | $255,922 | FY2025 |
| 36C24E25N0260 | BOOZ ALLEN HAMILTON INC | RPO EAST (36C24E) | $1,878,280 | FY2025 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24017J0422_3600_VA24013D0054_3600 · retrieved 2026-09-26.